Innate immune responses against mRNA vaccine promote cellular immunity through IFN-β at the injection site.

Publication date: Aug 27, 2024

mRNA vaccines against SARS-CoV-2 have revolutionized vaccine development, but their immunological mechanisms are not fully understood. Here, we investigate injection site responses of mRNA vaccines by generating a comprehensive single-cell transcriptome profile upon lipid nanoparticle (LNP) or LNP-mRNA challenge in female BALB/c mice. We show that LNP-induced stromal pro-inflammatory responses and mRNA-elicited type I interferon responses dominate the initial injection site responses. By tracking the fate of delivered mRNA, we discover that injection site fibroblasts are highly enriched with the delivered mRNA and that they express IFN-β specifically in response to the mRNA component, not to the LNP component of mRNA vaccines. Moreover, the mRNA-LNP, but not LNP alone, induces migratory dendritic cells highly expressing IFN-stimulated genes (mDC_ISGs) at the injection site and draining lymph nodes. When co-injected with LNP-subunit vaccine, IFN-β induces mDC_ISGs at the injection site, and importantly, it substantially enhances antigen-specific cellular immune responses. Furthermore, blocking IFN-β signaling at the injection site significantly decreases mRNA vaccine-induced cellular immune responses. Collectively, these data highlight the importance of injection site fibroblasts and IFN-β signaling during early immune responses against the mRNA vaccine and provide detailed information on the initial chain of immune reactions elicited by mRNA vaccine injection.

Open Access PDF

Concepts Keywords
Fibroblasts Animals
Mice COVID-19
Nanoparticle COVID-19 Vaccines
Pro COVID-19 Vaccines
Vaccines Dendritic Cells
Female
Fibroblasts
Immunity, Cellular
Immunity, Innate
Interferon-beta
Interferon-beta
Lipid Nanoparticles
Lipids
Lipids
Liposomes
Liposomes
Mice
mRNA Vaccines
mRNA Vaccines
Nanoparticles
RNA, Messenger
RNA, Messenger
SARS-CoV-2
Single-Cell Analysis

Original Article

(Visited 1 times, 1 visits today)